drugset / Trial / NCT02948881

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

NCT02948881

Phase 4 Completed 100 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to estimate the effect of oral Boniva (ibandronate sodium)taken once monthly versus placebo on bone quality and strength at the hip at one year.

Timeline

Start
2005-08
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibandronate Other / unclassified 150 mg Oral

Indications